1.212EUR+4.48%Mkt Cap: 26.07M EURP/E: —Last update: 2026-05-14
Valbiotis SA engages in the research and development of dietary supplements to prevent metabolic and cardiovascular diseases in France and Asia. The company offers supplements for immunity and vitality, health and wellbe…
Industry Peers
Packaged Foodsloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)-11.02
PEG—
P/B3.75
P/S28.81
EV/EBITDA-2.44
EV/Revenue24.84
EPS (TTM)-0.47
EPS (Forward)-0.10
Cash Flow & Leverage
FCF Yield-17.95%
FCF Margin-517.15%
Operating CF-8.04M EUR
CapEx (TTM)151.00K EUR
Net Debt/EBITDA0.39
Net Debt-3.59M EUR
Technical
SMA 501.019 (+18.9%)
SMA 2000.8570 (+41.4%)
Beta-0.25
S&P 52W Chg24.23%
Avg Vol (30d)162.71K
Avg Vol (10d)237.47K
Technical Indicators
RSI (14)72.7
MACD0.0179
MACD Signal-0.0081
MACD Hist.+0.0259
BB Upper1.156 EUR
BB Middle0.9992 EUR
BB Lower0.8422 EUR
BB Width31.43%
ATR (14)0.0752 EUR
Vol Ratio (20d)2.21x
52W Range
0.535089% of range1.296
52W High1.296 EUR
52W Low0.5350 EUR
Profitability
Gross Margin-146.19%
EBITDA Margin0.00%
Profit Margin-1040.55%
Oper. Margin-844.06%
ROE-135.28%
ROA-65.45%
Revenue Growth305.70%
Earnings Growth—
Balance Sheet
Debt/Equity0.73
Current Ratio2.85
Quick Ratio2.22
Book Value/Sh0.2940 EUR
Cash/Share0.3670 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Ownership
Shares Out.23.66M
Float22.95M
Insiders3.86%
Institutions1.57%
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)2.500 EUR
Target Range2.300 EUR – 2.700 EUR
# Analysts2
Company
Market Cap26.07M EUR
Enterprise Value22.48M EUR
Revenue (TTM)905.00K EUR
Gross Profit-1.32M EUR
Net Income (TTM)-9.42M EUR
Revenue/Share0.0460 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees50
Last Price1.212 EUR
CountryFR
SectorConsumer Defensive
IndustryPackaged Foods
ISINFR0013254851